Surgical treatment of persistent hyperparathyroidism after renal transplantation

Annals of Surgery

Volumn 248, Issue 1, 2008, Pages 18-30

  Triponez, Frédéric ^a,c   Clark, Orlo H ^b   Vanrenthergem, Yves ^c   Evenepoel, Pieter ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; NAPHTHALENE DERIVATIVE;

BONE DENSITY; BONE MINERALIZATION; CALCIUM BLOOD LEVEL; CRYOPRESERVATION; DATA BASE; DETERIORATION; DISEASE SEVERITY; DRUG COST; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPARATHYROIDISM; IMAGING; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NERVE PARALYSIS; OUTCOME ASSESSMENT; PARATHYROIDECTOMY; PATHOGENESIS; PATIENT MONITORING; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; THYMECTOMY; TREATMENT INDICATION; WOUND DEHISCENCE; CHRONIC KIDNEY FAILURE; DIAGNOSTIC IMAGING; DISEASE COURSE; HYPOPHOSPHATEMIA; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION;

CRYOPRESERVATION; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MONITORING, INTRAOPERATIVE; NAPHTHALENES; PARATHYROID HORMONE; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATIONS; THYMECTOMY;

EID: 48949118965     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181728a2d     Document Type: Review

References (165)

1. Llach F. Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis. 1995;25:663-679.
2. Slatopolsky E. The role of calcium, phosphorus and vitamin D metabolism in the development of secondary hyperparathyroidism. Nephrol Dial Transplant1998;13(suppl 3):3-8.
3. Messa P, Sindici C, Cannella G, et al. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int. 1998;54:1704-1713.
4. Malberti F, Farina M, Imbasciati E. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrol Dial Transplant. 1999;14:2398-2406.
5. Dumoulin G, Hory B, Nguyen NU, et al. No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients. Am J Kidney Dis. 1997;29:746-753.
6. Drueke TB. Primary and secondary uraemic hyperparathyroidism: from initial clinical observations to recent findings. Nephrol Dial Transplant. 1998;13:1384-1387.
7. Nieto J, Ruiz-Cuevas P, Escuder A, et al. Tertiary hyperparathyroidism after renal transplantation. Pediatr Nephrol. 1997;11:65-68.
8. Parfitt AM. The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int. 1997;52:3-9.
9. Tominaga Y. Mechanism of parathyroid tumourigenesis in uraemia. Nephrol Dial Transplant. 1999;14(suppl 1):63-65.
10. Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006; 69:1945-1953.
11. Bro S, Olgaard K. Effects of excess PTH on nonclassical target organs. Am J Kidney Dis. 1997;30:606-620.
12. Cohen EP, Moulder JE. Parathyroidectomy in chronic renal failure: has medical care reduced the need for surgery? Nephron. 2001;89:271-273.
13. Reis A, Hecht W, Groger R, et al. Cloning and sequence analysis of the human parathyroid hormone gene region. Hum Genet. 1990;84:119-124.
14. Segre GV, Niall HD, Habener JF, et al. Metabolism of parathyroid hormone: physiologic and clinical significance. Am J Med. 1974;56:774-784.
15. Brossard JH, Cloutier M, Roy L, et al. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. JClin Endocrinol Metab. 1996;81:3923-3929.
16. Lepage R, Roy L, Brossard JH, et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem. 1998;44:805-809.
17. John MR, Goodman WG, Gao P, et al. A novel immunoradiometric assay detects full-length human PTH but not amino- terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab. 1999;84:4287-4290.
18. Gao P, Scheibel S, D'Amour P, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment ofparathyroid function. J Bone Miner Res. 2001;16:605-614.
19. Bonarek H, Merville P, Bonarek M, et al. Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int. 1999; 56:642-649.
20. Evenepoel P, Claes K, Kuypers D, et al. Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single- centre study. Nephrol Dial Transplant. 2004;19:1281-1287.
21. Parfitt AM. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab. 1982;8:92-112.
22. Reinhardt W, Bartelworth H, Jockenhovel F, et al. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant. 1998;13:436 -442.
23. Heaf J, Tvedegaard E, Kanstrup IL, et al. Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant. 2000;14:457-463.
24. Castleman B, Kibbee BU. Case records of the Massachusetts General Hospital: case 46 -1963. N Engl J Med. 1963;269:97-101.
25. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(suppl 3):S1-S201.
26. Clark OH, Stark DA, Duh QY, et al. Value ofhigh resolution real-time ultrasonography in secondary hyperparathyroidism. Am J Surg. 1985;150:9 -17.
27. Torres A, Rodriguez AP, Concepcion MT, et al. Parathyroid function in long-term renal transplant patients: importance of pre-transplant PTH concentrations. Nephrol Dial Transplant. 1998;13(suppl 3):94-97.
28. Caravaca F, Fernandez MA, Cubero J, et al. Are plasma 1,25-dihy- droxyvitamin D3 concentrations appropriate after successful kidney transplantation? Nephrol Dial Transplant. 1998;13(suppl 3):91-93.
29. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol. 2002;13:551-558.
30. Gwinner W, Suppa S, Mengel M, et al. Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant. 2005;5:1934-1941.
31. Evenepoel P, Naesens M, Claes K, et al. Tertiary "hyperphosphatonin- ism" accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant. 2007;7:1193-1200.
32. Setterberg L, Sandberg J, Elinder CG, et al. Bone demineralization after renal transplantation: contribution of secondary hyperparathyroid- ism manifested by hypercalcaemia. Nephrol Dial Transplant. 1996;11:1825-1828.
33. Cunningham J. Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression. J Am Soc Nephrol. 2007;18:223-234.
34. Rojas E, Carlini RG, Clesca P, et al. The pathogenesis of osteodystro- phy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int. 2003;63:1915-1923.
35. Carlini RG, Rojas E, Weisinger JR, et al. Bone disease in patients with long-term renal transplantation and normal renal function. Am J KidneyDis. 2000;36:160-166.
36. Dissanayake IR, Epstein S. The fate of bone after renal transplantation. Curr Opin Nephrol Hypertens. 1998;7:389-395.
37. Nagano N. Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Pharmacol Ther. 2006;109:339 -365.
38. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350:1516-1525.
39. Kruse AE, Eisenberger U, Frey FJ, et al. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2005;20:1311-1314.
40. Szwarc I, Argiles A, Garrigue V, et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperpara- thyroidism. Transplantation. 2006;82:675-680.
41. Serra AL, Schwarz AA, Wick FH, et al. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant. 2005;20:1315-1319.
42. Peacock M, Bilezikian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyper- parathyroidism. J Clin Endocrinol Metab. 2005;90:135-141.
43. Moe SM, Cunningham J, Bommer J, et al. Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. NephrolDial Transplant. 2005;20:2186-2193.
44. Shahapuni I, Monge M, Oprisiu R, et al. Drug Insight: renal indications of calcimimetics. Nat Clin Pract Nephrol. 2006;2:316 -325.
45. Evenepoel P. Calcimimetics in chronic kidney disease: evidence, opportunities and challenges. Kidney Int. In press.
46. Malberti F, Marcelli D, Conte F, et al. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol. 2001;12:1242-1248.
47. D'Alessandro AM, Melzer JS, Pirsch JD, et al. Tertiary hyperparathy- roidism after renal transplantation: operative indications. Surgery. 1989;106:1049 -1055.
48. Vlcek J, Binswanger U, Keusch G, et al. Hyperparathyroidism after kidney transplantation: a retrospective case controlled study. Klin Wochenschr. 1991;69:669 -673.
49. Kerby JD, Rue LW, Blair H, et al. Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg. 1998;227:878-886.
50. Kilgo MS, Pirsch JD, Warner TF, et al. Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery. 1998;124:677-683.
51. Schmid T, Muller P, Spelsberg F. Parathyroidectomy after renal transplantation: a retrospective analysis of long-term outcome. Nephrol Dial Transplant. 1997;12:2393-2396.
52. Mourad M, Malaise J, Chautems RC, et al. Early posttransplant calcemia as a predictive indicator for parathyroidectomy in kidney allograft recipients with tertiary hyperparathyroidism. Transplant Proc. 2000;32:437-440.
53. Kinnaert P, Nagy N, Decoster-Gervy C, et al. Persistent hyperparathy- roidism requiring surgical treatment after kidney transplantation. World J Surg. 2000;24:1391-1395.
54. Evenepoel P, Claes K, Kuypers DR, et al. Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transplant. 2007;22:1730 -1737.
55. Evenepoel P, Vandenbergh B, Naessens M, et al. Parathyroid hormone accentuates hypercalcemia and elevated calcitriol levels in renal transplant recipients in the early posttransplant period. J Am Soc Nephrol. 2007;18:749A.
56. Tominaga Y, Numano M, Tanaka Y, et al. Surgical treatment of renal hyperparathyroidism. Semin Surg Oncol. 1997;13:87-96.
57. Taniguchi M, Tokumoto M, Matsuo D, et al. Persistent hyperparathy- roidism in renal allograft recipients: vitamin D receptor, calcium- sensing receptor, and apoptosis. Kidney Int. 2006;70:363-370.
58. Giangrande A, Castiglioni A, Solbiati L, et al. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism. Nephrol Dial Transplant. 1992;7:412-421.
59. Bergenfelz A, Kanngiesser V, Zielke A, et al. Conventional bilateral cervical exploration versus open minimally invasive parathyroidec- tomy under local anaesthesia for primary hyperparathyroidism. Br J Surg. 2005;92:190-197.
60. Bergenfelz A, Lindblom P, Tibblin S, et al. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236:543-551.
61. Russell CF, Dolan SJ, Laird JD. Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg. 2006;93:418 -421.
62. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;11:49-54.
63. Bilezikian JP, Potts JT Jr, Fuleihan Gel H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res. 2002;17(suppl 2):N2-N11.
64. Haciyanli M, Lal G, Morita E, et al. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg. 2003;197:739 -746.
65. Sebag F, Hubbard JG, Maweja S, et al. Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery. 2003;134:1038 -1041.
66. Milas M, Weber CJ. Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery. 2004;136:1252-1260.
67. Kebebew E, Duh QY, Clark OH. Tertiary hyperparathyroidism: histo- logic patterns of disease and results of parathyroidectomy. Arch Surg. 2004;139:974-977.
68. Thanasoulis L, Bingener J, Sirinek K, et al. A successful application of the intraoperative parathyroid hormone assay in tertiary hyperparathy- roidism. Am Surg. 2007;73:281-283.
69. Nichol PF, Mack E, Bianco J, et al. Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism. Surgery. 2003;134:713-717.
70. Pellitteri PK. Directed parathyroid exploration: evolution and evaluation of this approach in a single-institution review of 346 patients. Laryngoscope. 2003;113:1857-1869.
71. Pattou FN, Pellissier LC, Noel C, et al. Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hy- perparathyroidism. World JSurg. 2000;24:1330 -1334.
72. Seehofer D, Steinmuller T, Rayes N, et al. Parathyroid hormone venous sampling before reoperative surgery in renal hyperparathyroidism: comparison with noninvasive localization procedures and review of the literature. Arch Surg. 2004;139:1331-1338.
73. Wells SA Jr, Debenedetti MK, Doherty GM. Recurrent or persistent hyperparathyroidism. J Bone Miner Res. 2002;17(suppl 2):N158 - N162.
74. Caron NR, Sturgeon C, Clark OH. Persistent and recurrent hyperpara- thyroidism. Curr Treat Options Oncol. 2004;5:335-345.
75. Guillem P, Vlaeminck-Guillem V, Dracon M, et al. L'imagerie preop- eratoire des hyperparathyroidies des insuffisants renaux a- t- elle un interet en pratique clinique? Ann Chir. 2006;131:27-33.
76. Triponez F, Dosseh D, Hazzan M, et al. Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation. Br J Surg. 2005;92:1282-1287.
77. Lo CY, Lang BH, Chan WF, et al. A prospective evaluation of preoperative localization by technetium-99m sestamibi scintigraphy and ultrasonography in primary hyperparathyroidism. Am J Surg. 2007;193:155-159.
78. Muros MA, Bravo Soto J, Lopez Ruiz JM, et al. Two-phase scintig- raphy with technetium 99m-sestamibi in patients with hyperparathy- roidism due to chronic renal failure. Am J Surg. 2007;193:438 -442.
79. Perie S, Fessi H, Tassart M, et al. Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123/technetium Tc 99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathy- roidism. Am J Kidney Dis. 2005;45:344-352.
80. McPhaul JJ, McIntosh D, Hammond W, et al. Autonomous secondary (renal) parathyroid hyperplasia. N Engl J Med. 1964;271:1342.
81. Tominaga Y, Uchida K, Haba T, et al. More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroid- ism. Am J Kidney Dis. 2001;38(4 suppl 1):S168-S171.
82. Gasparri G, Camandona M, Abbona GC, et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroid- ectomies. Ann Surg. 2001;233:65-69.
83. Sancho JJ, Sitges-Serra A. Surgical approach to secondary hyperpara- thyroidism. In: Clark OH, Duh QY, eds. Textbook of Endocrine SurgeryVol. 50. San Francisco: WB Saunders Company; 1997:403-409.
84. Rothmund M, Wagner PK, Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg. 1991;15:745-750.
85. Tominaga Y, Johansson H, Takagi H. Secondary hyperparathyroidism: pathophysiology, histopathology, and medical and surgical management. Surg Today. 1997;27:787-792.
86. U.S. Renal Data System, USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2004. Available at: http://www.usrds.org/at- las.htm.
87. Kaczirek K, Prager G, Riss P, et al. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperpara- thyroidism. Arch Surg. 2006;141:129-134.
88. Sitges-Serra A, Caralps-Riera A. Hyperparathyroidism associated with renal disease. Pathogenesis, natural history, and surgical treatment. Surg Clin North Am. 1987;67:359 -377.
89. Nichol PF, Starling JR, Mack E, et al. Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg. 2002;235:673-678.
90. Krause MW, Hedinger CE. Pathologic study of parathyroid glands in tertiary hyperparathyroidism. Hum Pathol. 1985;16:772-784.
91. Tominaga Y, Katayama A, Sato T, et al. Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant. 2003;18 (suppl 3):iii65-iii70.
92. Triponez F, Kebebew E, Dosseh D, et al. Less- than- subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery. 2006;140:990-997.
93. Saxe AW, Gibson GW, Kay S. Characterization of a simplified method of cryopreserving human parathyroid tissue. Surgery. 1990;108(6): 1033-1038; discussion 1038-1039.
94. Cohen MS, Dilley WG, Wells SA Jr, et al. Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective analysis. Surgery. 2005;138:1033-1040.
95. Akerstrom G, Malmaeus J, Bergstrom R. Surgical anatomy of human parathyroid glands. Surgery. 1984;95:14-21.
96. Punch JD, Thompson NW, Merion RM. Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients: a 25-year single- center experience. Arch Surg. 1995;130:538-542.
97. Pereira JA, Jimeno J, Miquel J, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery. 2005;138:1095-100; discussion 1100-1101.
98. Nussbaum SR, Thompson AR, Hutcheson KA, et al. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery. 1988;104:1121-1127.
99. Irvin GL III, Prudhomme DL, Deriso GT, et al. A new approach to parathyroidectomy. Ann Surg. 1994;219:574-579.
100. 00. Johnson LR, Doherty G, Lairmore T, et al. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin Chem. 2001;47:919-925.
101. 01. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665-670.
102. 02. Fahy BN, Bold RJ, Beckett L, et al. Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg. 2002;137): 917-922.
103. 03. Westerdahl J, Bergenfelz A. Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraopera- tive parathyroid hormone. World J Surg. 2004;28:1132-1138.
104. 04. Lokey J, Pattou F, Mondragon-Sanchez A, et al. Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism-a consecutive series of 80 patients. Surgery. 2000;128:1029 -1034.
105. 05. Chou FF, Lee CH, Chen JB, et al. Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg. 2002;137:341-344.
106. 06. Seehofer D, Rayes N, Klupp J, et al. Predictive value of intact parathyroid hormone measurement during surgery for renal hyperpara- thyroidism. Langenbecks Arch Surg. 2005;390:222-229.
107. 07. Kaczirek K, Riss P, Wunderer G, et al. Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroid- ism. Surgery. 2005;137:431-435.
108. 08. Haustein SV, Mack E, Starling JR, et al. The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroid- ism after renal transplantation. Surgery. 2005;138:1066 -1071.
109. 09. Lorenz K, Dralle H. Will intra-operative measurement of parathyroid hormone alter the surgical concept of renal hyperparathyroidism? Langenbecks Arch Surg. 2005;390:277-279.
110. Triponez F, Dosseh D, Hazzan M, et al. Accuracy of intra- operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. Langenbecks Arch Surg. 2006;391:561-565.
111. Bieglmayer C, Kaczirek K, Prager G, et al. Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroid- ism: pilot study of the impact of renal function and assay specificity. Clin Chem. 2006;52:1112-1119.
112. Yamashita H, Gao P, Cantor T, et al. Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery. 2004;135:149-156.
113. Saxe AW, Baier R, Tesluk H, et al. The role of the pathologist in the surgical treatment of hyperparathyroidism. Surg Gynecol Obstet. 1985;161:101-105.
114. Hosking SW, Jones H, du Boulay CE, et al. Surgery for parathyroid adenoma and hyperplasia: relationship of histology to outcome. Head Neck. 1993;15:24-28.
115. Westra WH, Pritchett DD, Udelsman R. Intraoperative confirmation of parathyroid tissue during parathyroid exploration: a retrospective evaluation of the frozen section. Am J Surg Pathol. 1998;22:538-544.
116. Elliott DD, Monroe DP, Perrier ND. Parathyroid histopathology: is it of any value today? J Am Coll Surg. 2006;203:758-765.
117. Dewan AK, Kapadia SB, Hollenbeak CS, et al. Is routine frozen section necessary for parathyroid surgery? Otolaryngol Head Neck Surg. 2005;133:857-862.
118. Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery. 2004;136:1310 -1322.
119. Moore C, Lampe H, Agrawal S. Predictability of hypocalcemia using early postoperative serum calcium levels. J Otolaryngol. 2001;30:266 -270.
120. Cozzolino M, Gallieni M, Corsi C, et al. Management of calcium refilling post-parathyroidectomy in end-stage renal disease. J Nephrol. 2004;17:3-8.
121. Sheikh MS, Ramirez A, Emmett M, et al. Role of vitamin D- dependent and vitamin D- independent mechanisms in absorption of food calcium. J Clin Invest. 1988;81:126-132.
122. Mazzaferro S, Chicca S, Pasquali M, et al. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration. Nephrol Dial Transplant. 2000;15:877-882.
123. Coen G, Mazzaferro S, De Antoni E, et al. Procollagen type 1 C- terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients. Am J Nephrol. 1994;14:106 -112.
124. Urena P, Prieur P, Petrover M. [Alkaline phosphatase of bone origin in hemodialyzed patients. 110 assays]. Presse Med. 1996;25:1320-1325.
125. Yajima A, Inaba M, Ogawa Y, et al. Significance of time-course changes of serum bone markers after parathyroidectomy in patients with uraemic hyperparathyroidism. Nephrol Dial Transplant. 2007;22: 1645-1657.
126. Abdelhadi M, Nordenstrom J. Bone mineral recovery after parathy- roidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab. 1998;83:3845-3851.
127. Collaud S, Staub -Zahner T, Trombetti AC, et al. Significant increase in bone mineral density after successful parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. World J Surg. 2008. Mar 1 (epub ahead of print). In press.
128. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 8. Bone disease. Nephrol Dial Transplant. 2002;17 (suppl 4):43-48.
129. Brandenburg VM, Westenfeld R, Ketteler M. The fate of bone after renal transplantation. J Nephrol. 2004;17:190-204.
130. Dempster DW. Bone histomorphometry in glucocorticoid -induced osteoporosis. J Bone Miner Res. 1989;4:137-141.
131. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogen- esis and management. Ann Intern Med. 1990;112:352-364.
132. Palmer SC, Strippoli GF, McGregor DO. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis. 2005;45:638 -649.
133. David DS, Sakai S, Brennan BL, et al. Hypercalcemia after renal transplantation. Long-term follow-up data. N Engl J Med. 1973;289: 398-401.
134. Geis WP, Popovtzer MM, Corman JL, et al. The diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surg Gynecol Obstet. 1973;137:997-1010.
135. Rostaing L, Moreau-Gaudry X, Baron E, et al. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Clin Nephrol. 1997;47:248 -255.
136. Lee PP, Schiffmann L, Offermann G, et al. Effects of parathyroidectomy on renal allograft survival. Kidney Blood Press Res. 2004;27:191-196.
137. Evenepoel P, Claes K, Kuypers D, et al. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant. 2005;20:1714-1720.
138. Schwarz A, Rustien G, Merkel S, et al. Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant. 2007;22:584-591.
139. Massfelder T, Parekh N, Endlich K, et al. Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol. 1996;118:1995-2000.
140. Ogata H, Ritz E, Odoni G, et al. Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol. 2003;14:959-967.
141. Schleiffer R, Xue H, McCarron DA, et al. Effect of chronic and subacute parathyroidectomy on blood pressure and resistance artery contractility in the spontaneously hypertensive rat. J Hypertens. 1993; 11:709-716.
142. Odenwald T, Nakagawa K, Hadtstein C, et al. Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. J Am Soc Nephrol. 2006;17:655-662.
143. Almirall J, Lopez T, Comerma I, et al. Effect of parathyroidectomy on blood pressure in dialysis patients. Nephron. 2002;92:495-496.
144. Massry SG, Iseki K, Campese VM. Serum calcium, parathyroid hormone, and blood pressure. Am JNephrol. 1986;6(suppl 1):19 -28.
145. Barenbrock M, Hausberg M, Kosch M, et al. Effect of hyperparathyroidism on arterial distensibility in renal transplant recipients. KidneyInt. 1998;54:210-5.
146. Lewanczuk RZ, Benishin CG, Shan J, et al. Clinical aspects of parathyroid hypertensive factor. J Cardiovasc Pharmacol. 1994;23(suppl 2):S23-S26.
147. Shigematsu T, Caverzasio J, Bonjour JP. Parathyroid removal prevents the progression of chronic renal failure induced by high protein diet. Kidney Int. 1993;44:173-181.
148. Hagstrom E, Lundgren E, Lithell H, et al. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf). 2002;56:253-260.
149. Akmal M, Kasim SE, Soliman AR, et al. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int. 1990;37:854-858.
150. Klin M, Smogorzewski M, Ni Z, et al. Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. J Clin Invest. 1996;97:2167-2173.
151. Roullet JB, Lacour B, Yvert JP, et al. Correction by insulin of disturbed TG-rich LP metabolism in rats with chronic renal failure. Am J Physiol. 1986;250:E373-E376.
152. McIntosh DA, Peterson EW, McPhaul JJ Jr. Autonomy of parathyroid function after renal homotransplantation. Ann Intern Med. 1966;65:900 -907.
153. Diethelm AG, Edwards RP, Whelchel JD. The natural history and surgical treatment of hypercalcemia before and after renal transplantation. Surg Gynecol Obstet. 1982;154:481-490.
154. Malmaeus J, Akerstrom G, Johansson H, et al. Parathyroid surgery in chronic renal insufficiency. Subtotal parathyroidectomy versus total parathyroidectomy with autotransplantation to the forearm. Acta Chir Scand. 1982;148:229-238.
155. Delmonico FL, Wang CA, Rubin NT, et al. Parathyroid surgery in patients with renal failure. Ann Surg. 1984;200:644-647.
156. Garvin PJ, Castaneda M, Linderer R, et al. Management of hypercalcemic hyperparathyroidism after renal transplantation. Arch Surg. 1985;120:578-583.
157. McCarron DA, Lenfesty B, Vetto M, et al. Total parathyroidectomy for posttransplantation hyperparathyroidism. Transplantation. 1985;40:266 -269.
158. Alexander PT, Schuman ES, Vetto RM, et al. Repeat parathyroid operation associated with renal disease. Am J Surg. 1988;155:686-689.
159. Sitges-Serra A, Esteller E, Ricart MJ, et al. Indications and late results of subtotal parathyroidectomy for hyperparathyroidism after renal transplantation. World J Surg. 1984;8:534-539.
160. Buchmann P, Keusch G, Ittner J, et al. Tertiary hyperparathyroidism after cadaver-kidney transplantation. Transplant Proc. 1984;16:1324.
161. Botha JR. Renal hyperparathyroidism. Surg Annu. 1992;24(Pt 2):43-57.
162. Neonakis E, Wheeler MH, Krishnan H, et al. Results of surgical treatment of renal hyperparathyroidism. Arch Surg. 1995;130:643-648.
163. Fang JT, Chuang CK, Chu SH, et al. Tertiary hyperparathyroidism after renal transplantation. Transplant Proc. 1996;28:1484-1485.
164. Garcia A, Mazuecos A, Garcia T, et al. Effect of parathyroidectomy on renal graft function. Transplant Proc. 2005;37:1459 -1461.
165. Pajda M, Matug A, Widlak M, et al. Influence of parathyroidectomy on blood pressure and function of the transplanted kidney in patients with tertiary hyperparathyroidism. Ann Transplant. 2006;11:11-15.